NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$9.30
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SCMP stock logo

About (SCMP) Stock (NASDAQ:SCMP)

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

SCMP Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
See More Headlines
Receive SCMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
4/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
CUSIP
86490910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Peter S. Greenleaf (Age 47)
    Chairman of the Board, Chief Executive Officer
  • Peter P. Pfreundschuh CPA (Age 48)
    Chief Financial Officer
  • Max Donley (Age 48)
    Executive Vice President of Global Human Resources, Information Technology and Strategy
  • Matthias Alder (Age 52)
    Executive Vice President
  • Peter A. Kiener Ph.D. (Age 64)
    Chief Scientific Officer
  • Alex Driggs (Age 41)
    General Counsel, Corporate Secretary
  • Peter Lichtlen M.D. (Age 47)
    Ph.D., Chief Medical Officer
  • John H. Johnson (Age 58)
    Lead Independent Director
  • Paul R. Edick (Age 62)
    Director
  • Daniel P. Getman Ph.D. (Age 59)
    Director

SCMP Stock Analysis - Frequently Asked Questions

How were (SCMP)'s earnings last quarter?

(SCMP) (NASDAQ:SCMP) posted its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. The biopharmaceutical company had revenue of $61.27 million for the quarter, compared to analysts' expectations of $58.05 million. (SCMP)'s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.30 earnings per share.

What other stocks do shareholders of (SCMP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SCMP) investors own include XOMA (XOMA), SentinelOne (S), Alnylam Pharmaceuticals (ALNY), Teekay Tankers (TNK), Xenon Pharmaceuticals (XENE), Gilead Sciences (GILD), OPKO Health (OPK), Cisco Systems (CSCO), Infinera (INFN) and Micron Technology (MU).

This page (NASDAQ:SCMP) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners